LUP Statistics
Record
- Title
- Lenalidomide-bendamustine-rituximab in untreated mantle cell lymphoma > 65 years, the Nordic Lymphoma Group phase I+II trial NLG-MCL4
- Type
- Journal Article
- Publ. year
- 2016
- Author/s
- Albertsson-Lindblad, Alexandra; Kolstad, Arne; Laurell, Anna; Räty, Riikka et al.
- Department/s
- Lymphoma - Clinical Research; Tumor microenvironment; BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
- In LUP since
- 2016-10-13
Downloads
| Total | This Year | This Month |
| 309 | 0 | 0 |
United States of America  |
174 (56%) |
China  |
37 (12%) |
Germany  |
16 (5%) |
Sweden  |
12 (4%) |
Russian Federation  |
6 (2%) |
France  |
5 (2%) |
Japan  |
4 (1%) |
Viet Nam  |
4 (1%) |
Ireland  |
4 (1%) |
Hong Kong (China)  |
3 (1%) |
Denmark  |
3 (1%) |
Unknown  |
3 (1%) |
Mexico  |
3 (1%) |
Ukraine  |
3 (1%) |
Australia  |
3 (1%) |
South Korea  |
3 (1%) |
United Kingdom of Great Britain and Northern Ireland  |
2 (1%) |
Nigeria  |
2 (1%) |
Lithuania  |
2 (1%) |
Greece  |
2 (1%) |
Brazil  |
2 (1%) |
Czechia  |
2 (1%) |
Canada  |
2 (1%) |
Saudi Arabia  |
1 (0%) |
Netherlands (Kingdom of the)  |
1 (0%) |
Taiwan (China)  |
1 (0%) |
India  |
1 (0%) |
Italy  |
1 (0%) |
Indonesia  |
1 (0%) |
Singapore  |
1 (0%) |
Colombia  |
1 (0%) |
Poland  |
1 (0%) |
Switzerland  |
1 (0%) |
Spain  |
1 (0%) |
Norway  |
1 (0%) |